Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-10000980Phase 2Recruiting
Phase 2, randomised trial in breast cancer comparing Placebo control group with Triptorelin group (2 arms). Primary endpoint: Ovarian reserve at 6 months after chemotherapy. Started Jan 2008; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-10000980.